Histopathological reporting of resected carcinomas of the oesophagus and gastro-oesophageal junction

Acta Gastro-Enterologica Belgica

Volumn 67, Issue 1, 2004, Pages 28-33

  Ectors, N ^a   Geboes, K ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LUGOL; PARAFFIN;

CANCER GRADING; CANCER INVASION; CANCER STAGING; ESOPHAGUS CARCINOMA; HISTOPATHOLOGY; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE; METASTASIS; PERINEURIUM; REVIEW;

ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FORMS AND RECORDS CONTROL; HUMANS; MEDICAL RECORDS; NEOPLASM STAGING; PATHOLOGY;

EID: 2142759673     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. KOHN L.T., CORRIGAN J.M., DONALDSON M.S. eds. To err is human: building a safer health system. Washington DC: National Academic Press, 1999.
2. th century. Washington DC: Institute of Medicine, National Academic Press, 2001.
3. Association of Directors of Anatomic, Surgical Pathology. Recommendations on quality control and quality insurance in Anatomic Pathology. Am. J. Surg. Pathol., 1991, 15: 1007-1009.
4. HAGGITT R.C., APPELMAN H.D., LEWIN K.J., RIDDELL R.H. Recommendations for the reporting of resected esophageal carcinomas. Association of Directors of Anatomic Surgical Pathology. Hum. Pathol., 2000, 31: 1188-1190.
5. Association of Directors of Anatomic and Surgical Pathology, recommendations for the reporting of resected esophageal carcinomas. Virchows Arch., 2000, 437: 348-350.
6. Recommendations for the reporting of resected esophageal carcinomas. Association of directors of anatomic and surgical pathology. Am. J. Clin. Pathol., 2000, 114: 512-514.
7. Recommendations for the reporting of resected esophageal carcinomas. Association of directors of anatomic and surgical pathology. Mod. Pathol., 2000, 13: 1034-1037.
8. SIU K.F., CHEUNG H.C., WONG J. Shrinkage of the esophagus after resection of carcinoma. Ann. Surg., 1986, 203: 173-176.
9. WITTEKIND C., HENSON D.E., HUTTER R.V.P. et al. TNM supplement. A commentary on uniform use, 2nd ed. New York: Wiley-Liss, 2001.
10. Minimum data set for oesophageal carcinoma - histopathology reports. Mapstone N. Royal College of Pathologists. www.rcpath.org/activities/publications.
11. MORI M., MIMORI K., SADANAGA N. et al. Polypoid carcinoma of the oesophagus. Japanese Journal of Cancer Research, 1994, 85: 1131-1136.
12. IBRAHIM N.B.N. Guidelines for handling oesophageal biopsies and resection specimens and their reporting. Best Practice N° 155 ACP. J. Clin. Pathol., 2000, 53: 89-94.
13. SOBIN L.H., WITTEKIND CH., eds. TNM classification of malignant tumours. 6th ed., Wiley-Liss, New York, 2002.
14. LIEBERMAN M.D., SHRIVER C.D., BLECKNER S., BURT M. Carcinoma of the esophagus: prognostic significance of histologic type. J. Thor. Cardiovasc. Surg., 1995, 109: 130-138.
15. PARAF F., FLÉJOU J.-F., PIGNON J.-P., FÉKÉTÉ F., POTET F. Surgical pathology of adenocarcinoma arising in Barrett's esophagus: an analysis of 67 cases. Am. J. Surg. Pathol., 1995, 19: 183-191.
16. PATIL P., REDKAR A., PATEL S.G. et al. Prognosis of operable squamous-cell carcinoma of the esophagus - relationship with clinicopathological features and DNA-ploidy. Cancer, 1993, 72: 20-24.
17. IDE H., NAKAMURA T., HAYASHI K. et al. Esophageal squamous-cell carcinoma - pathology and prognosis. World Journal of Surgery, 1994, 18: 321-330.
18. HOLSCHER A.H., BOLLSCHWEILER E., SCHNEIDER P.M. et al. Prognosis of early esophageal cancer - comparison between adenocarcinoma and squamous-cell carcinoma. Cancer, 1995, 76: 178-186.
19. ROBEYCAFFERTY S.S., ELNAGGAR A.K., SAHIN A.A. et al. Prognostic factors in esophageal squamous carcinoma - a study of histologic features, blood-group expression, and DNA ploidy. Am. J. of Clin. Path., 1991, 95: 844-849.
20. GALL C.A., RIEGER N.A., WATTCHOW D.A. Positive proximal resection margins after resection for carcinoma of the esophagus and stomach - effect on survival and symptom recurrence. Aus. and N. Z. J. of Surg., 1996, 66: 734-737.
21. TSUTSUI S., KUWANO H., WATANABE M. et al. Resection margin for squamous-cell carcinoma of the esophagus. Ann. of Surg., 1995, 222: 193-202.
22. DRIESSEN A., MOONS J., ALAERTS H., NAFTEUX P., HAUSTERMANS K., VAN CUTSEM E., LERUT T., ECTORS N. Circumferential resection margin involvement - a postoperative predictor of survival in distal oesophageal and cardia cancer (in preparation).
23. DEXTER S.P., SUE-LING H., MCMAHON M.J., QUIRKE P., MAPSTONE N., MARTIN I.G. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut, 2001, 48: 667-670.
24. IZBICKI J.R., HOSCH B., PILCHMEIER U. et al. Prognostic value of immunohistochemically identifiable tumour cells in lymph nodes of patients with completely resected esophageal cancer. N. E. J. of Med., 1997, 337: 1188-1194.
25. LERUT T., COOSEMANS W., DECKER G., DE LEYN P., ECTORS N., FIEUWS S., MOONS J., NAFTEUX P., VAN RAEMDONCK D., Leuven Collaborative Workgroup for Esophageal Carcinoma. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagas and gastroesophageal junction. J. Thorac. Cardiovasc. Surg., 2003, 126: 1121-8.
26. BHANSALI M., FUJITA H., KAKEGAWA T. et al. Pattern of recurrence after extended radical esophagectomy with three field lymph node dissecion for squamous cell carcinoma in the thoracic esophagus. World J. of Surg, 1997, 21: 275-281.
27. WATANABE H., JASS J.R., SOBIN L.H. Histologic typing of oesophageal and gastric tumours: World Health Organization, 2nd edn. Springer, Berlin Heidelberg New York, 1990.
28. SOBIN L., WITTEKIND C., eds. TNM classification of malignant tumours. 5th ed. John Wiley & Sons Inc: New York, 1997.
29. THEUNISSEN P., BORCHARD F., POORTVLIET D.C.J. Histopathological evaluation of esophageal-carcinoma - the significance of venous invasion. B. J. of Surg, 1991, 78: 930-932.
30. LAM K., MA L.T., WONG J. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J. Clin. Pathol., 1996, 49: 124-129.
31. SARBIA M., MOLSBERGER G., WILLERS R. et al. The prognostic-significance of DNA-ploidy in adenocarcinomas of the esophagogastric junction. J. of Cancer Res. and Clin. Oncol., 1996, 122: 186-188.
32. TAKEBAYASHI Y., NATUGOE S., BABA M. et al. Angiogenesis in esophageal squamous cell carcinoma. Oncol. Rep., 1998, 5: 401-404.
33. LAGORCEPAGES C., PARAF F., DUBOIS S. et al. Expression of CD44 in premalignant and malignant Barrett's oesophagus. Histopathology, 1998, 32: 7-14.
34. YACOUB L., GOLDMAN H., ODZE R.D. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's associated neoplasia: Correlation with prognosis. Mod. Pathol., 1997,10: 105-112.